Physician profile
Olivia Stransky
NPI 1417390428
$4,234.70
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $814 · 2021: $2,704 · 2022: $33.52 · 2023: $355 · 2024: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $473.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gemini Mountain Medical, LLC | $3,043.44 | 2020-2021 | |
| Smith+Nephew, INC. | $349.51 | 2019-2023 | Grafix Pl, Regranex, Collagenase Santyl |
| Organogenesis INC. | $211.30 | 2021-2024 | Puraply |
| Treace Medical Concepts, INC. | $179.76 | 2021-2023 | |
| Celularity INC. | $113.50 | 2020 | |
| Vaporox, INC. | $86.23 | 2024 | Vht-200 Wound Treatment System |
| Stryker Corporation | $71.30 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $47.49 | 2019 | |
| Arteriocyte Medical Systems, INC. | $29.63 | 2020 | |
| Zimmer Biomet Holdings, INC. | $27.19 | 2020 | |
| Paragon 28, INC. | $26.43 | 2019-2021 | |
| Abbott Laboratories | $24.48 | 2021 | |
| Bioventus LLC | $12.61 | 2019 | |
| Kci USA, INC. | $11.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Stransky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.